Back to discover
Disease

Pathologic Complete Response

Emerging research
3
Publications
1
Related conditions
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Research activity

3 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes7
  • Lung Neoplasms2
  • Neoadjuvant Therapy2
  • Carcinoma, Non-Small-Cell Lung1
  • Immune Checkpoint Inhibitors1
  • Leukemia1
  • Receptors, Chimeric Antigen1
  • Stomach Neoplasms1
Leading journals3
  • Journal for immunotherapy of cancer1
  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer1
  • Nature medicine1
Leading researchers8
  • Forde PM2
  • Anders RA1
  • Balli D1
  • Baras AS1
  • Bestvina CM1
  • Botta GP1
  • Bushong J1
  • Cai J1
Affiliations (unnormalised)6
  • Bloomberg-Kimmel Institute for Cancer Immunotherapy2
  • Aberdeen Royal Infirmary1
  • Ascension Saint Francis Hospital1
  • Cambridge Institute1
  • City of Hope Comprehensive Cancer Center1
  • Department of Clinical Oncology1

Related conditions

1 match

Diseases frequently studied alongside this one. Number shows shared papers.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

The disappearance of all signs of a disease upon REMISSION INDUCTION as supported by pathological examination.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.